Therapeutic applications of somatostatin analogues

Expert Opinion on Therapeutic Patents

Volumn 8, Issue 7, 1998, Pages 855-870

  Osapay, G ^a   Osapay, K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Agonist; Binding affinity; Cancer therapy; Diagnostics; Glucagon; Growth hormone; Insulin; Lanreotide; Lanthionine; Non peptide; Octreotide; Peptide analogue; Peptidomimetics; Prolactin; Radio guided surgery; Radiolabelled; Receptor; Sandostatin; Somatostatin; SRIF

Indexed keywords

ANGIOPEPTIN; BIM 23064; CELL SURFACE RECEPTOR; DEXTRO PHENYLALANYLPHENYLALANYLPHENYLALANYL DEXTRO TRYPTOPHYLLYSYLTHREONYLPHENYLALANYLTHREONINAMIDE; DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYL DEXTRO [3 (2 NAPHTHYL)ALANINAMIDE]; DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYLTHREONINAMIDE; L 362855; NC 8 12; OCTREOTIDE; RECEPTOR SUBTYPE; SEGLITIDE; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; VAPREOTIDE;

ALZHEIMER DISEASE; CANCER THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; DRUG RECEPTOR BINDING; EPILEPSY; GLUCAGON RELEASE; HISTOCHEMISTRY; INSULIN RELEASE; ISOTOPE LABELING; RECEPTOR DENSITY; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION;

EID: 0031842752     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.8.7.855     Document Type: Review

References (78)